Episode

Pfizer chases monthly edge

Podcast
Wall Street Breakfast
Published
Jun 8, 2026
Duration seconds
261
Processing state
not_requested
Canonical source
https://seekingalpha.com/wsb?source=wsb_podcast:pfizer_chases_monthly_edge
Audio
https://api.spreaker.com/download/episode/72416304/wsb060826.mp3
JSON
/v1/public/podcasts/wall-street-breakfast-618041/episodes/pfizer-chases-monthly-edge
Markdown
/podcast/wall-street-breakfast-618041/pfizer-chases-monthly-edge.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/wall-street-breakfast-618041/episodes/pfizer-chases-monthly-edge/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/wall-street-breakfast-618041/pfizer-chases-monthly-edge.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

Pfizer (PFE) says mid-stage trial data support monthly dosing for GLP-1 therapy. (00:13) Introducing Archy IQ: McDonald's (MCD) new AI drive-thru system. (01:03) Marvell Technology (MRVL), Flex (FLEX) jump on S&P 500 inclusion plan. Episode transcripts seekingalpha.com/wsb . Show links: Biggest stock movers Monday: NRIX, HON, and more Tech sell-off can be a buying opportunity, says Nvidia CEO Jensen Huang Strait of Hormuz to remain open but with transit fees, Iran envoy to Moscow quoted AI World Cup predictions: the machines love France Sign up for our daily newsletter here and for full access to analyst ratings, stock quant scores, dividend grades, subscribe to Seeking Alpha Premium at seekingalpha.com/subscriptions .